| Català | Español | English

Homepage

Research Areas

Human Experimental Neuropsychopharmacology

Coordinator
Jordi Riba
jriba@santpau.cat

HSCSP RI
Collaborators
Natalia Roberto
Ion Yarritu
Alejandra Roldán

HSCSP RI
HSCSP RI
HSCSP
 
Main Lines of Research

General neuropsychopharmacology:
  • Pharmacological modulation of the different neurotransmission systems so as to study the role of these systems in advanced cognitive functions (executive control) and emotion.
Neuropsychopharmacology of abused substances:
  • Study of the effects on the central nervous system of psychodysleptic drugs such as ayahuasca, salvinorin A, dimethyltryptamine and THC.
  • Assessment of the impact of long-term drug use on brain function (fMRI) and structure (VBM, DTI).
Challenges
  • Consolidate existing research lines and extend them through possible cooperation agreements with other groups and according to the growth of the group itself.
  • Obtain emerging-group recognition for the Experimental Human Neuropsychopharmacology.
  • Obtain stable funding for the group and support in terms of technical staff.
  • Communicate our activities.
  • Maintain existing external cooperation agreements.
  • Establish new cooperation agreements within the HSCSP Research Institute.
Active Grants
  • Riba J. Functional magnetic resonance evaluation of reward processing and executive functions in cocaine-dependent subjects. FIS Grant. Carlos III Health Institute. January 2008-June 2012.
Collaborations with other IIB Sant Pau Groups
  • Pharmacokinetic/Pharmacodynamic Modelling and Simulation.
  • Parkinson Disease and Movement Disorders.
  • Clinical Psychiatry.
Scientific Production

Total of Publications with an Impact Factor / 6
Total Impact Factor / 20.338
Mean Impact Factor / 3.389
 

 

 



 

© 2002-2009 Polymita Technologies. All rights reserved.